AI agents collaborate to generate biomedical hypotheses and analyse data, moving towards a laboratory discovery cycle with AI involved in every step.
30 June 2026
AI agents collaborate to generate biomedical hypotheses and analyse data, moving towards a laboratory discovery cycle with AI involved in every step.
By
Olivier Elemento
Olivier Elemento is in the Englander Institute for Precision Medicine, Department of Systems and Computational Biomedicine, Weill Cornell Medicine, New York City 10021, USA.
AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Stanford deploys AI scientist agents to accelerate drug discovery timelines from months to days
An Overlooked Opportunity To Bend The Curve On Cancer Care
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery
Systems can generate hypotheses, interpret data and suggest ways to develop medicines.
Hear the biggest stories from the world of science | 20 May 2026
Drug companies are betting AI can fix the slow, expensive process of testing new drugs in humans.
Both tools generate hypotheses; one goes on to analyze some of the data.
Two benchmarks developed at Ai2 – ScienceWorld and DiscoveryWorld – reveal that even incredibly strong AI science agents struggle…
Edison Scientific and investment firm Population Health Partners are teaming up to leverage AI agents in drug discovery and…
